首次癫痫发作患者的癌症风险
结果显示首次发作后1年内任何癌症绝对风险4.1%、SIR 5.30,神经系统癌症SIR高达76.1;1至5年及5至20年风险轻度升高。提示首次癫痫发作可能是隐匿性癌症的早期临床信号。
要点
- 首次癫痫发作后1年内癌症相对风险显著升高,尤其神经系统癌症。
- 短期绝对风险4.1%,长期随访仍见轻度风险升高。
- 对部分患者首次发作后应考虑更广泛的诊断评估。
核心结论
- 首次癫痫发作与短期癌症相对风险明显升高及长期风险轻度升高相关,可能是神经性与非神经性隐匿癌症的早期临床信号。
主要发现
- 首次发作后1年内观察到神经系统癌症1172例、非神经系统癌症850例,任何癌症绝对风险4.1%、SIR 5.30(95%CI 5.07-5.54)。
- 1至小于5年观察到神经系统癌症87例、非神经系统癌症1226例,任何癌症绝对风险3.5%、SIR 1.18(95%CI 1.12-1.25)。
- 5至20年观察到神经系统癌症112例、非神经系统癌症2120例,任何癌症绝对风险13.4%、SIR 1.34(95%CI 1.28-1.40)。
- 1年内神经系统癌症绝对风险2.4%、SIR 76.1(95%CI 71.8-80.6),非神经系统癌症绝对风险1.7%、SIR 2.32(95%CI 2.17-2.48)。
关键数值与推荐
- 1年内任何癌症绝对风险4.1%,SIR 5.30(95%CI 5.07-5.54)。
- 1年内神经系统癌症绝对风险2.4%,SIR 76.1(95%CI 71.8-80.6)。
- 1年内非神经系统癌症绝对风险1.7%,SIR 2.32(95%CI 2.17-2.48)。
临床怎么用
- 对首次癫痫发作的成人,尤其选择性病例,应考虑超越常规癫痫评估的 broader 诊断检查以排查隐匿癌症。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Seizures are a known complication of cancer, but whether they may be the first sign of undiagnosed neurological and nonneurological cancer remains unclear. OBJECTIVE: To examine neurological and nonneurological cancer risk in patients with first-time seizures vs the general population. DESIGN, SETTING, AND PARTICIPANTS: This population-based cohort study was conducted using nationwide Danish medical registries from January 1996 through December 2022. Follow-up extended until cancer diagnosis (excluding nonmelanoma skin cancer), emigration, death, or December 31, 2022. Analyses were performed from January 2025 through December 2025. All persons aged 18 years or older with a first-time hospital diagnosis of seizure and no preceding cancer were included. EXPOSURE: First-time seizure diagnosis. MAIN OUTCOMES AND MEASURES: The primary outcomes were absolute risks (ARs) of cancer and standardized incidence ratios (SIRs) relative to the general Danish population with 95% confidence intervals, which were computed for all cancers, neurological and nonneurological cancers, and site-specific cancer within 1 year, from 1 to less than 5 years, and from 5 to 20 years after the first seizure. RESULTS: Among 49 894 adults with first-time seizure (median [IQR] age at seizure diagnosis, 51.5 [35.6-67.8] years; 20 648 [41.4%] women), a total of 1172 neurological and 850 nonneurological cancers were observed within the first year of follow-up; 87 neurological and 1226 nonneurological cancers were observed during the period from 1 to less than 5 years; and 112 neurological and 2120 nonneurological cancers were observed during the period from 5 to 20 years. In these time periods, the ARs for any cancer were 4.1%, 3.5%, and 13.4%, with SIRs of 5.30 (95% CI, 5.07-5.54), 1.18 (95% CI, 1.12-1.25), and 1.34 (95% CI, 1.28-1.40). ARs for neurological cancers were 2.4%, 0.2%, and 0.7%, with SIRs of 76.1 (95% CI, 71.8-80.6), 1.85 (95% CI, 1.48-2.28), and 1.46 (95% CI, 1.20-1.75). ARs for nonneurological cancers were 1.7%, 3.3%, and 12.8%, with SIRs of 2.32 (95% CI, 2.17-2.48), 1.15 (95% CI, 1.09-1.22), and 1.33 (95% CI, 1.28-1.39). CONCLUSIONS AND RELEVANCE: Per the results of this cohort study, first-time seizures were associated with clearly elevated short-term relative risk of cancer and slightly elevated long-term risk, indicating they may be an early clinical sign of both neurological and nonneurological occult cancers. These findings highlight the importance of considering broader diagnostic assessments after first-time seizures in select patients.
引用
- Pedersen AL, Farkas DK, Fuglsang CH, et al. Risk of Cancer in Patients With First-Time Seizure. JAMA Neurol. 2026. PMID: 42043826. doi:10.1001/jamaneurol.2026.0894
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。